Abstract:
BioTrove, Inc. announced today that the Company has acquired an exclusive license from Stanford University for patent applications that cover the use of a through-hole structured microarray to perform PCR. Separately, BioTrove has been issued a patent on a novel method using the Company's proprietary OpenArray(TM) platform for high-density cell assay and culture.